Endothelial progenitor cells, bronchopulmonary dysplasia and other short-term outcomes of extremely preterm birth

Early Human Development

Volumn 87, Issue 7, 2011, Pages 461-465

  Paviotti, Giulia ^a   Fadini, Gian Paolo ^a   Boscaro, Elisa ^a   Agostini, Carlo ^a   Avogaro, Angelo ^a   Chiandetti, Lino ^a   Baraldi, Eugenio ^a   Filippone, Marco ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Bronchopulmonary dysplasia; Endothelial progenitor cells; Patent ductus arteriosus; Prematurity

Indexed keywords

ANTIBIOTIC AGENT; CD133 ANTIGEN; CD34 ANTIGEN; CORTICOSTEROID; OXYGEN; SURFACTANT; VASCULOTROPIN RECEPTOR 2;

ANTIBIOTIC THERAPY; ANTIGEN EXPRESSION; ARTICLE; ARTIFICIAL VENTILATION; BIRTH; BIRTH WEIGHT; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DISEASE ASSOCIATION; ENDOTHELIAL PROGENITOR CELL; ERYTHROCYTE COUNT; EXTREMELY PREMATURE NEWBORN; FEMALE; FLOW CYTOMETRY; GESTATIONAL AGE; HUMAN; HUMAN CELL; INFANT; LEUKOCYTE COUNT; LUNG DYSPLASIA; MALE; MENSTRUATION; MORTALITY; NECROTIZING ENTEROCOLITIS; NEWBORN; OUTCOME ASSESSMENT; OXYGEN THERAPY; PATENT DUCTUS ARTERIOSUS; PHENOTYPE; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RESPIRATORY TRACT INTUBATION; RETROLENTAL FIBROPLASIA; SEPSIS; THROMBOCYTE COUNT;

BLOOD CELL COUNT; BRONCHOPULMONARY DYSPLASIA; COHORT STUDIES; DUCTUS ARTERIOSUS, PATENT; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; ITALY; PREGNANCY; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; STEM CELLS;

EID: 79958276966     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2011.03.011     Document Type: Article

References (40)

1. Fanaroff A.A., Stoll B.J., Wright L.L., Carlo W.A., Ehrenkranz R.A., Stark R.A., et al. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 2007, 196:147.e1-147.e8.
2. Jobe A.H. The "new" BPD: an arrest of lung development. Pediatr Res 1999, 46:641-643.
3. Baraldi E., Filippone M. Chronic lung disease after premature birth. N Engl J Med 2007, 357:1946-1955.
4. Bhatt A.J., Pryhuber G.S., Huyck H., Watkins R.H., Metlay L.A., Maniscalco W.M. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001, 164:1971-1980.
5. Abman S.H. Bronchopulmonary dusplasia: a "vascular hypothesis". Am J Respir Crit Care Med 2001, 164:1755-1756.
6. Jakkula M., Le Cras T.D., Gebb S., Hirth K.P., Tuder R.M., Voelkel N.F., Abman H. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 2000, 279:L600-L607.
7. Maniscalco W.M., Watkins R.H., Pryhuber G.S., Bhatt A., Shea C., Huyck H. Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. Am J Physiol Lung Cell Mol Physiol 2002, 282(4):L811-L823.
8. Thébaud B., Ladha F., Michelakis E.D., Sawicka M., Thurston G., Eaton F., et al. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation 2005, 112(16):2477-2486.
9. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
10. Asahara T., Masuda H., Takahashi T., Kalca C., Pastore C., Silver M., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999, 85:221-228.
11. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999, 5:434-438.
12. Burnham E.L., Taylor W.R., Quyyumi A.A., Rojas M., Brigham K.L., Moss M. Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. Am J Respir Crit Care Med 2005, 172(7):854-860.
13. Yamada M., Kubo H., Ishizawa K., Kobayashi S., Shinkawa M., Sasaki H. Increased circulating endothelial progenitor cells in patients with bacterial pneumonia: evidence that bone marrow derived cells contribute to lung repair. Thorax 2005, 60:410-413.
14. Fadini G.P., Schiavon M., Cantini M., Baesso I., Facco M., Miorin M., et al. Circulating progenitor cells are reduced in patients with severe lung disease. Stem Cells 2006, 24:1806-1813.
15. Thebaud B., Abman S.H. Bronchopulmonary dysplasia-where have all the vessel gone? Roles of angiogenic growth factors in chronic lung disease. Am J Respir Crit Care Med 2007, 175:978-985.
16. Balasubramaniam V., Mervis C.F., Maxey A.M., Markham N.E., Abman S.H. Hyperoxia reduces bone marrow, circulating and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2007, 292:L1073-L1084.
17. Borghesi A., Massa M., Campanelli R., Bollani L., Tzialla C., et al. Circulating endothelial progenitor cells in preterm infants with bronchopulmonary dysplasia. Am J Respir Crit Care Med 2009, 180:540-546.
18. Kluckow M., Evans N. Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr 1995, 127:774-779.
19. Evans N., Iyer P. Longitudinal changes in the diameter of the ductus arteriosus in ventilated preterm infants: correlation with respiratory outcomes. Arch Dis Child Fetal Neonatal Ed 1995, 72:F156-F161.
20. Fadini G.P., Baesso I., Albiero M., Sartore S., Agostini C., Avogaro A. Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis 2008, 97(2):496-503.
21. Balasubramaniam V., Ingram D.A. Endothelial progenitor cells in the risk of developing bronchopulmonary dysplasia. Am J Respir Crit Care Med 2009, 180:488-490.
22. Baker C.D., Ryan S.L., Ingram D.A., Seedorf G.J., Abman S.H., Balasubramaniam V. Endothelial colony-forming cells from preterm infants are increased and more susceptible to hyperoxia. Am J Respir Crit Care Med 2009, 180:454-461.
23. Sieveking D.P., BA, Celermajer D.S., Ng M.K. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J Am Coll Cardiol 2008, 51(6):660-668.
24. Case J., Mead L.E., Bessler W.K., Prater D., White HA, Saadatzadeh MR, et al. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 2007, 35(7):1109-1118.
25. Leor J., Marber M. Endothelial progenitor cells: a new tower of Babel?. J Am Coll Cardiol 2006, 48(8):1588-1590.
26. Peichev M., Naiyer A.J., Pereira D., Zhu Z., Lane W.J., Williams M., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000, 95(3):952-958.
27. Fadini G.P., Avogaro A. Cell-based methods for ex vivo evaluation of human endothelial biology. Cardiovasc Res 2010, 87(1):12-21.
28. Schmidt-Lucke C., Fichtlscherer S., Aicher A., Tschöpe C., Schultheiss H.P., Zeiher A.M., et al. Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol. PLoS One 2005, 5(11):e13790.
29. Werner N., Kosiol S., Schiegl T., Ahlers P., Walenta K., Link A., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005, 353(10):999-1007.
30. Schmidt-Lucke C., Rössig L., Fichtlscherer S., Vasa M., Britten M., Kämper U. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005, 111(22):2981-2987.
31. Jobe A.H., Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001, 163:1723-1729.
32. Bizzarro M.J., Bhandari V., Krause D.S., Smith B.R., Gross I. Circulating stem cells in extremely preterm neonates. Acta Paediatr 2007, 96:521-525.
33. Clyman R.I., Chan C.Y., Mauray F., Chen Y.Q., Cox W., Seidner S.R., et al. Permanent anatomic closure of the ductus arteriosus in newborn baboons: the roles of postnatal constriction, hypoxia, and gestation. Pediatr Res 1999, 45:19-29.
34. Clyman R.I., Seidner S.R., Kajino H., Roman C., Koch C.J., Ferrara N., et al. VEGF regulates remodelling during permanent anatomic closure of the ductus arteriosus. Am J Physiol 2002, 282:R199-R206.
35. Echtler K., Stark K., Lorenz M., Kerstan S., Walch A., Jennen L., et al. Platelets contribute to postnatal occlusion of the ductus arteriosus. Nat Med 2010, 16(1):75-82.
36. Boo N.Y., Mohd-Amin I., Bilkis A.A., Yong-Junina F. Predictors of failed closure of patent ductus arteriosus with indomethacin. Singapore Med J 2006, 47(9):763.
37. Bancalari E., Claure N., Gonzalez A. Patent ductus arteriosus and respiratory outcome in premature infants. Biol Neonate 2005, 88(3):192-201.
38. Dollberg S., Lusky A., Reichman B. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study. J Pediatr Gastroenterol Nutr 2005, 40(2):184-188.
39. Ryder R.W., Shelton J.D., Guinan M.E. Necrotizing enterocolitis: a prospective multicenter investigation. Am J Epidemiol 1980, 112:113-123.
40. Evans N., Kluckow M. Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed 1996, 75(3):F183-F186.